ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.92
0.07%
US Tech 100
20,603.63
-0.04%
S&P 500
6,037.39
-0.16%
US Dollar vs CAD
1.40759
0.22%
Bitcoin
95,172.03
-0.73%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Argen X SE (ARGX) Share Price

Argen X SE

Argen X SE (ARGX)

argenx SE
588.20
-1.60
(-0.27%)
Closed December 03 10:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
588.20
Bid
586.00
Ask
596.00
Volume
38,969
587.40 Day's Range 595.20
271.00 52 Week Range 595.20
Market Cap
34.818B
Previous Close
589.80
Open
589.00
Last Trade
51
@
588.2
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
63,051
Shares Outstanding
59,194,000
Dividend Yield
-
PE Ratio
-117.89
Earnings Per Share (EPS)
-4.98
Revenue
1.27B
Net Profit
-295.05M

About Argen X SE

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.argenx.com
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 589.80 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 595.20 €.

Argen X currently has 59,194,000 shares outstanding. The market capitalization of Argen X is 34.91 € billion. Argen X has a price to earnings ratio (PE ratio) of -117.89.

Ask ADVFN Intelligence (AI)

ARGX Latest News

More News

argenx to Present at Upcoming Investor Conferences

November 26, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

November 26 2024
GlobeNewswire Inc.

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for...

November 20 2024
GlobeNewswire Inc.

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

First and only NMPA-approved treatment for patients with CIDP in China  Second VYVGART Hytrulo indication approved in China  November 11, 2024 – 7:30am ET  Amsterdam, the Netherlands— argenx...

November 11 2024
GlobeNewswire Inc.

argenx to Participate at Upcoming Investor Conferences

November 5, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

November 05 2024
GlobeNewswire Inc.

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

$573 million in third quarter global net product sales CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Management to host conference...

October 31 2024
GlobeNewswire Inc.

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

October 24, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

October 24 2024
GlobeNewswire Inc.

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability...

October 15 2024
GlobeNewswire Inc.

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced...

September 19 2024
GlobeNewswire Inc.

argenx to Present at Upcoming Investor Conferences

August 28, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

August 28 2024
GlobeNewswire Inc.

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

$478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

July 25 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
15.40.926561427591582.8595.2572.847687584.8906621DE
446.48.56404577335541.8595.2527.869301567.10772326DE
1290.918.278705007497.3595.2456.363051522.80520704DE
26248.273340595.2338.462913471.84515506DE
52171.941.2923372568416.3595.227163311414.14753379DE
156328.3126.317814544259.9595.2224.165668371.7567332DE
260455.2342.255639098133595.293.0575518293.74908472DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M

Discussion

View Full Feed
manibiotech manibiotech 4 minutes ago
And from paid pumpers and apologists also mean nothing to me 
NWBO
BlazingStocks BlazingStocks 4 minutes ago
$FAVO - The company President - Shaun Quin is featured on the cover of the November issue of Business Honor, which highlights key companies making a significant impact across America through their innovation, growth, and excellence. In the issue, he discusses FAVO Capital's vision and purpose, as we
FAVO
PumpersExposed PumpersExposed 4 minutes ago
It is funny isn't it.. Can't defend the tech, can't defend the management, can't defend the 'deal du-jour' of the moment with yet again another unknown oil player.. but hey! Bashers are here so it MUST be a great stock!
QSEP
Bubae Bubae 4 minutes ago
Link for context please. Looks like you got that info from your echo chamber. Press release linked below for context from the left leaning Washington Post.

Trump grants clemency to 143 people in late-night pardon blast
January 20, 2021
https://www.washingtonpost.com/poli
GRST
prototype_101 prototype_101 5 minutes ago
dude, exactly!!! Lebby set out SAM/SOM guidance at the 2023 ASM, in 2024 coincident with the ONE AND ONLY TIMELINE he has used since at least as far back as the 2019 ASM, the Customer Acceptance was set for 2024 with SAM/SAM guidance for 2024 of 7900 modulators which would have been indicative of SA
ASM LWLG
Gatsby Gatsby 5 minutes ago
Based on the FS, the Company has revenue and profits.
For the 9 months of 2024, net income is about 233K
Intrinsec value : book value about 1M usd (Assets minus liabilities)
Based on earnings : let's use a p/e of 10 and we get 2-3M usd
This is well below market cap.
JNSH
ElectricJester54 ElectricJester54 5 minutes ago
I have been desperately wanting one of my other investments to recover because they just announced a merger and yet its still sitting the red. I have been debating taking the loss so I can throw it in here and ZHUD because they are ticking time bombs to shoot up. I am trying to be patient waiting fo
ZHUD
ssc ssc 6 minutes ago
Hey anyone who likes the 7 years of silence from erhc management and/or believes the bullish "speculation" from erhe's largest shareholder guerguerian dickran, when are you going to buy this all the way up to dollars/share? Ok, I know that is ridiculous. How about 10 cents or even a penny? Don't t
ERHE
Skipperdog11 Skipperdog11 6 minutes ago
JRoon- from what is posted on stocktwits, they currently are filling 35 openings in Italy for reps. Seems a bit aggressive to me. I just can't believe that at this point in time Amarin exists as tiny company trying to do the work that is usually reserved for some of the largest organizations in the
AMRN
BIOChecker4 BIOChecker4 6 minutes ago
A dose of reality that runs counter to the approved WGT narrative always stings, doesn’t it? Anyone who dares to voice an opinion and poke the WGT bubble with facts is immediately labeled a FUDster or basher.

Only listening to the people you agree with could be detrimental to your fin
AVXL
linkvest linkvest 6 minutes ago
SOB.... they gave me .00105.... What bs
RDAR
chainma1l chainma1l 6 minutes ago
Unless it gets memed again--which it could--the only thing that I see happening is a reverse split. From my perspective, the reverse merger is a done deal, although that EcoTech situation was a done deal as well, and we know how that panned out.
I don't believe VPER has done anything substant
VPER
Donotunderstand Donotunderstand 6 minutes ago
Interesting

I agree with #1 of your points as you heard them

Treasury has to play ball

And #3 is interesting --- and in some form has been argued for 15 years - right?

Now my question

DOGE (the faux ag
FNMA
delerious1 delerious1 6 minutes ago
Ronn Inc. Ceo Invited to Attend and Speak About the Global Hydrogen Future at the World Economic Forum as Member of the Monaco Delegation in January 2025
Tuesday, 03 December 2024 09:00 AM

ACCESSWIRE | Article Logo
RONN


Company Update
SCOTT
LPHM RONN
Moonboy1 Moonboy1 6 minutes ago
This might take off like qub# did last week on the Denver news. Huge potential now in the spotlight. Just depends on dillution
BBAI
BigBadWolf BigBadWolf 6 minutes ago
a 5 digit execution ;-) Holiday Special :-D
RDAR
EOT EOT 7 minutes ago
Recent XRPUSD News…

Ripple XRP’s Price On The Brink Of Unbelievable All-Time Highs As Leak Reveals Mammoth December Bombshell • ZyCrypto • 12/03/2024
XRPUSD
snow snow 7 minutes ago
Stockton " look at the company financials, they speak for themself." Yes they speak for themselves. There is no profit but a substaintial loss as far as the bottom line is concerned.
IQST
prussian4profit prussian4profit 7 minutes ago
"Why

Such Hatred Of Biel?"

Oh, he claims he has no hatred of BIEL the company. He has hatred for the people that are positive on BIEL and its products. Check out his fairly recent posting history.

Consider the type of person that would claim this.
BIEL
Golden Cross Golden Cross 7 minutes ago
$ILLR Nice Red to Green move here today! Those dips are great for adding. Red to Green moves almost daily.
Strong news campaign underway! Glad to have my shares! Adding All Dips!

https://investorshub.advfn.com/uimage/uploads/2024/12/3/olbjkRG.png
ILLR
3331 3331 7 minutes ago
BIEL #5 BREAKOUT BOARD, #9 MOST READ (TODAY AND LAST HOUR), GOLDEN CROSS BLUE SKY BREAKOUT! 10 mil shares left at 4.....5 soon (yearly high)!
BIEL
TheKid5 TheKid5 7 minutes ago
22 days until Christmas
CLNV
PatB1 PatB1 8 minutes ago
How is there 0 volume on this today? Not a great sign of things to come!!
AFFU
linkvest linkvest 8 minutes ago
I'm going to try and grab 4 million of his now lol...
RDAR
Trooperstocks Trooperstocks 8 minutes ago
SGTM's appearance on Fox Business: https://www.otcmarkets.com/stock/SGTM/news/New-to-The-Street-on-Fox-Business-Premieres-Exclusive-Sponsored-Programming-Tonight-Featuring-Modular-Medical-NASDAQMODD?id=457017
SGTM

Your Recent History

EU
ARGX
Argen X
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved